Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison's disease)

Diabetes Technology and Therapeutics

Volumn 14, Issue 5, 2012, Pages 386-388

  Meyer, Gesine ^a   Hackemann, Annika ^a   Reusch, Juergen ^b   Badenhoop, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROCORTISONE;

ADDISON DISEASE; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DRUG EFFECT; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HORMONE SUBSTITUTION; HUMAN; MALE; MEDICAL INSTRUMENTATION; NOCTURNAL HYPOGLYCEMIA; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION;

ADDISON DISEASE; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; MALE; MIDDLE AGED; MONITORING, AMBULATORY; MONITORING, PHYSIOLOGIC; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84860556406     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0158     Document Type: Article

References (14)

1. Christiansen JJ, Djurhuus CB, Gravholt CH, Iversen P, Christiansen JS, Schmitz O, Weeke, J, Jorgensen JOL, Møller N: Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure. J Clin Endocrinol Metab 2007;92:3553-3559.
2. Klement J, Hubold C, Cords H, Oltmanns KM, Hallschmid M, Born J, Lehnert H, Peters A: High-calorie glucose-rich food attenuates neuroglycopenic symptoms in patients with Addison's disease. J Clin Endocrinol Metab 2010;95:522-528.
3. Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT, Ross RJ: Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol 2004;61:367-375.
4. Crown A, Lightman S: Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol 2005;63:483-492.
5. Woodward A, Weston P, Casson IF, Gill GV: Nocturnal hypoglycaemia in type 1 diabetes-frequency and predictive factors. Q J Med 2009;102:603-607.
6. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther 2010;12:679-684.
7. Bode BW, Battelino T: Continous glucose monitoring. Int J Clin Pract Suppl 2010;166:11-15.
8. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ: Performance evaluation of the Mini- Med continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2:49-56.
9. Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W, Allolio B: Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 2007;92:3912-3922.
10. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johansson G: Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006;91:4849-4853.
11. Arlt W, Rosenthal C, Hahner S, Allolio B: Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol 2006;64:384-389.
12. Rodriguez LM, Knight RJ, Heptulla RA: Continous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation. Diabetes Technol Ther 2010;12:347-351.
13. Lovas K, Husebye ES: Continous subcutaneous hydrocortisone infusion in Addison's disease. Eur J Endocrinol 2007; 157:109-112.
14. Johansson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S: Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol 2009;161:119-130.